Zacks' 7 Best Stocks for May, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/17/2013

Company Name Symbol %Change
VIASAT INC VSAT
19.35%
OLD SECOND B OSBC
5.76%
GAMCO INVEST GBL
4.61%
CORNING INC GLW
4.47%
SYNCHRONOSS SNCR
4.23%

Eastman, UNC Ink Research Pact

by Zacks Equity Research

February 27, 2013 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Eastman Chemical Company ( EMN - Analyst Report ) has entered into an agreement with Chapel Hill-based University of North Carolina (UNC) to conduct research in the fields of chemistry and materials science. The collaboration complements the earlier announced agreement between Eastman Chemical and North Carolina State University.

The agreement offers at least $1.5 million over a period of 6 years to aid the collaboration between Eastman Chemical scientists and UNC scientists, staff and students. Eastman Chemical and UNC will make joint efforts to bring innovative new ideas and technologies in market that run faster than traditional approaches.

This collaboration involves a series of programs including research projects, visits to both the UNC campus and Eastman Chemical manufacturing facilities and identifying and applying for federal or other funding opportunities.

Under the agreement, UNC’s chemistry faculty members will address Eastman Chemical developed problem statements or ‘Requests for Proposals’ (RFP) by submitting research proposals periodically. Eastman Chemical will then select the given UNC proposals for funding each year. The first decision regarding the projects is expected in spring 2013.

Last month, Eastman Chemical released its fourth-quarter 2012 results. The company slipped to a loss in the quarter hurt by losses related to pension benefit and other charges. Adjusted earnings, however, matched the Zacks Consensus Estimate. Revenues rose at a double-digit clip riding on the contributions of Solutia acquisition, but missed the Zacks Consensus Estimate.

Eastman Chemical’s diversified chemical portfolio, along with its integrated and diverse downstream businesses remains its strength. It also benefits from business restructuring, cost-cutting measures and increased capacity additions. However, the company remains exposed to weak pricing. Uncertainty regarding the timing of a recovery in Europe also remains as overhang.

Eastman Chemical currently maintains a Zacks Rank #2 (Buy).

Other companies in the chemical industry worth considering are Akzo Nobel NV ( AKZOY ) , Arkema S.A. ( ARKAY ) and BASF SE ( BASFY ) . All of these hold a Zacks Rank #1 (Strong Buy).

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.